Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,186.65. The company's market cap stands at 1.12T, with a P/E ratio of 43.81 and a dividend yield of 0.53%.
During the trading session on 2026-07-10, Eli Lilly(LLY) shares reached a daily high of $1,226.60 and a low of $1,178.32. At a current price of $1,186.65, the stock is +0.7% higher than the low and still -3.3% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 1.24M, versus its average volume of 3.39M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...
BofA raised the firm’s price target on Eli Lilly (LLY) to $1,334 from $1,251 and keeps a Buy rating on the shares. Second quarter results are expected to highli...
Key Points More Americans than ever are using GLP-1 drugs. Eli Lilly recently rolled out an oral weight loss drug. 10 stocks we like better than Eli Lilly ›...
Analyst ratings
84%
of 31 ratingsMore LLY News
Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma By Chris MacDonald Published Jul 9, 2:28PM EDT Quick Read LLY added $400 billion in market value over o...
Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59% By David Beren Published Jul 9, 12:18PM EDT Quick Read OZEM holds Lilly at 16% and No...
Eli Lilly (LLY) announced it will present 16 abstracts at the 2026 Alzheimer’s Association International Conference, AAIC,, July 12-15 in London. Three oral pre...
Eli Lilly’s (LLY) stock is getting a boost on an otherwise down day for markets as its drug to treat the skin condition eczema received a positive recommendatio...
Parkev Tatevosian, CFA has positions in Amazon and Eli Lilly. The Motley Fool has positions in and recommends Amazon, Eli Lilly, and Taiwan Semiconductor Manufa...
Key Points Eli Lilly's Mounjaro and Zepbound are the leading drugs in the GLP-1 space. The company's GLP-1 success has resulted in a lofty valuation for the s...
Stocks To Watch: 14 Names Test And Tease New Buy Zones 7/08/2026 A barrage of stocks to watch like Eli Lilly and Deere, show promise, alongside reminders to ke...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.